The Fund Grade · free · no account needed
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-09-01
BNY Mellon Global Stock Fund - Class A
#151 of 440 graded active funds · blend · large segment peer group
The point · specialist footprint
DGLAX puts more of its book behind proven specialists than 74% of graded funds.
Bottom 20%
Bottom 40%
Middle
● Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds on this rung beat bottom-rung funds by about 3.8 points per quarter, and beat the S&P in 43% of fund-quarters versus their 22%. The evidence argues this fund earns its seat.
2,825 graded funds · 2.7 years of filings, measured as they were published · evidence, not advice
The grade scores this fund's specialist share — the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
Conviction exposure
30.1%
of the book in specialist-converged names
Late-stage weight
25.3%
of the book in Crowded or Fading names
Active share
86.2%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book — top names by stage · as of 2026-09-09
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
DGLAX earns a B grade with specialists holding about 30% of the fund, and their early conviction on AMZN at 4.6% is the standout story here. The concern is a cluster of fading positions, APH, EW, ORLY, and TJX, that together represent real weight specialists are actively leaving.
→ Watch the four fading positions, APH, EW, ORLY, and TJX, to see if the fund trims them before further specialist exit.
→ Check whether the early conviction in AMZN and BKNG grows in future holdings, as that would confirm the fund is acting on its better signals.
Support leaving these positions
Read from today's disclosed book. Evidence, not advice.
The specialists — not the whales — are already positioned for what comes next. Stop finding out last.
Create your free accountNo card required · open the feed in 30 seconds